In general, GPR35-mediated signaling has been implicated in promoting anti-inflammatory responses and to prevent disease, including colitis [8,9], mast cell-mediated allergic reactions [10], and adipose tissue inflammation in obesity [11]. Here, GPR35 is linked to obesity disorder.